Literature DB >> 12654500

Role of the hippocampal CA2 region following postischemic hypothermia in gerbil.

Shiro Yamashita1, Osamu Miyamoto, Najma A Janjua, Kazuhito Tomizawa, Hideki Matsui, Takehiro Nakamura, Seigo Nagao, Toshifumi Itano.   

Abstract

To investigate the changes in the principal subunit of N-methyl-D-aspartate (NMDA) receptor 1 (NR1) following the transient ischemia and postischemic hypothermia, in situ hybridization was used in the gerbil hippocampus. One of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors, Glutamate receptor 2 (GluR2) was also investigated to compare with NR1. Even at 1 day, NR1 and GluR2 mRNAs in the CA1 region were reduced following ischemia. Although postischemic hypothermia prevented almost all the neuronal cell death by ischemia and inhibited the reduction of NR1 and GluR2 mRNAs in the CA1 region after 7 days, the downregulation of NR1 mRNA in the CA2 region was observed even at 1 day. This change was specific for NR1 and not for GluR2. These results suggest that the changes in NR1 and GluR2 receptors at the mRNA level would occur in spite of postischemic hypothermia. The phenomenon in the CA2 region may play an important role to rescue neuronal cell death by ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654500     DOI: 10.1016/s0169-328x(02)00664-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  2 in total

1.  The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy.

Authors:  W S Young; J Li; S R Wersinger; M Palkovits
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

2.  Galectin-3 expression in hippocampal CA2 following transient forebrain ischemia and its inhibition by hypothermia or antiapoptotic agents.

Authors:  Kenji Hisamatsu; Masayuki Niwa; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Akihiro Hirata; Yuichiro Hatano; Hiroyuki Tomita; Akira Hara
Journal:  Neuroreport       Date:  2016-03-23       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.